ACIR
@acir_org
Accelerating Cancer Immunotherapy Research. A free weekly digest of the latest findings in the field. We also make cool images :) Listen to @ImmunoTalks.
ID: 875012589985640450
http://ACIR.org 14-06-2017 15:30:33
4,4K Tweet
2,2K Takipçi
1,1K Takip Edilen
Porazzi and Nason et al. showed that EZH2 inhibition sensitizes a broad spectrum of tumors to diverse adoptive T cell immunotherapies. bit.ly/41x6cFS Marco Ruella
